At Novo Nordisk, we are committed to having a supplier base that represents the diverse patients who depend on us every day. We believe that by partnering with diverse suppliers who share our commitment to diversity, equity, inclusion and belonging (DEI&B), we gain an innovative perspective that enables us to strengthen our relationships and support the communities in which we operate as well as ultimately better support our patients.
Since beginning our Supplier Diversity program, we’ve created economic opportunities and helped grow diverse suppliers in multiple ways – by awarding business, through mentoring and, offering development opportunities. Today, small and diverse suppliers make up nearly half of our in-scope supplier base and over 17% of our in-scope spend. We continue to expand our small and diverse base and are constantly in search of meritorious suppliers to partner with. If that is you, we strongly encourage you to register with us.
We are proud to have been nominated for Diversity Alliance for Science’s Corporation of the Year in 2022 and 2023 and strive to build upon our program’s impact each year.